Cargando…
Prevention of cisplatin nephrotoxicity
Cisplatin has a well-established role in the treatment of broad spectrum of malignancies; however its use is limited because of cisplatin-induced nephrotoxicity (CIN) which can be progressive in more than 50% of cases. The most important risk factors for CIN include higher doses of cisplatin, previo...
Autores principales: | Hayati, Fatemeh, Hossainzadeh, Mehran, Shayanpour, Shokouh, Abedi-Gheshlaghi, Zahra, Beladi Mousavi, Seyed Seifollah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society of Diabetic Nephropathy Prevention
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5297508/ https://www.ncbi.nlm.nih.gov/pubmed/28197500 |
Ejemplares similares
-
Diabetes and end-stage renal disease; a review article on new concepts
por: Ghaderian, Seyed Bahman, et al.
Publicado: (2015) -
Erythropoietin; a review on current knowledge and new concepts
por: Tamadon, Mohamad-Reza, et al.
Publicado: (2013) -
Restless Legs Syndrome: Associated Risk Factors in Hemodialysis Patients
por: Beladi-Mousavi, Seyed Seifollah, et al.
Publicado: (2015) -
The theme of the world diabetes day 2014; healthy living and diabetes; a nephrology viewpoint
por: Beladi-Mousavi, Seyed Seifollah, et al.
Publicado: (2014) -
Hepatitis E Virus Infection Among Chronic Hemodialysis
por: Shayanpour, Shokouh, et al.
Publicado: (2016)